These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8829743)

  • 1. Effectiveness of clozapine in hospitalised people with chronic neuroleptic-resistant schizophrenia.
    Avnon M; Rabinowitz J
    Br J Psychiatry; 1995 Dec; 167(6):760-4. PubMed ID: 8829743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-resistant schizophrenia--the role of clozapine.
    Meltzer HY
    Curr Med Res Opin; 1997; 14(1):1-20. PubMed ID: 9524789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials.
    Wahlbeck K; Cheine M; Essali A; Adams C
    Am J Psychiatry; 1999 Jul; 156(7):990-9. PubMed ID: 10401441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
    Jalenques I; Coudert AJ
    Acta Psychiatr Belg; 1992; 92(6):323-38. PubMed ID: 1364281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia.
    Turetz M; Mozes T; Toren P; Chernauzan N; Yoran-Hegesh R; Mester R; Wittenberg N; Tyano S; Weizman A
    Br J Psychiatry; 1997 Jun; 170():507-10. PubMed ID: 9330014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients.
    Spivak B; Mester R; Wittenberg N; Maman Z; Weizman A
    Clin Neuropharmacol; 1997 Oct; 20(5):442-6. PubMed ID: 9331521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience with clozapine in Woodbridge Hospital.
    Wong KE; Chong SA; Ngui F; Winslow M; Devan GS; Leong OK; Choo CH
    Singapore Med J; 1997 Aug; 38(8):336-8. PubMed ID: 9364887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine versus typical neuroleptic medication for schizophrenia.
    Wahlbeck K; Cheine M; Essali MA
    Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
    Litman RE; Su TP; Potter WZ; Hong WW; Pickar D
    Br J Psychiatry; 1996 May; 168(5):571-9. PubMed ID: 8733795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with clozapine in 55 cases of treatment-resistant schizophrenia].
    Enomoto T; Ito T; Sekine K; Yasui R; Ashizawa Y; Uju Y; Hayakawa T; Tsukada K
    Seishin Shinkeigaku Zasshi; 2013; 115(9):953-66. PubMed ID: 24228473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?
    Carpenter WT; Zito JM; Vitrai J; Volavka J
    Biol Psychiatry; 1998 Jan; 43(2):79-83. PubMed ID: 9474440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
    Nyakyoma K; Morriss R
    Psychopharmacol Bull; 2010; 43(2):67-81. PubMed ID: 21052043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
    Pickar D; Bartko JJ
    Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia.
    De Risio A; Pancheri A; Simonetti G; Giannarelli D; Stefanutto L; Gentile B
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1112-6. PubMed ID: 21447367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
    Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.